Kevin C. Tang
2017
In 2017, Kevin C. Tang earned a total compensation of $1 as Chairman and Chief Executive Officer at Odonate Therapeutics, which was the same as previous year.
Compensation breakdown
| Salary | $1 |
|---|---|
| Total | $1 |
Tang received $1 in salary, accounting for 100% of the total pay in 2017.
Rankings
In 2017, Kevin C. Tang's compensation ranked 14,666th out of 14,666 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 14,666 out of 14,666 | 0th |
Division Manufacturing | 5,771 out of 5,772 | 0th |
Major group Chemicals And Allied Products | 2,075 out of 2,075 | 0th |
Industry group Drugs | 1,731 out of 1,731 | 0th |
Industry Pharmaceutical Preparations | 1,333 out of 1,333 | 0th |
Source: SEC filing on June 1, 2018.
Tang's colleagues
We found two more compensation records of executives who worked with Kevin C. Tang at Odonate Therapeutics in 2017.
News
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2020 pay falls 31% to $1.4M
June 1, 2021
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2019 pay jumps 37% to $2M
May 15, 2020
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2018 pay jumps 465% to $1.4M
June 24, 2019